PP
LAB icon

Paloma Partners’s Standard BioTools LAB Stock Holding History

Paloma Partners’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,183
Closed -$21.6K – 712
2024
Q3 		$21.6K Buy
+11,183
New +$21.9K ﹤0.01% 1092
2020
Q4 		– Sell
-26,467
Closed -$197K – 1959
2020
Q3 		$197K Sell
26,467
-13,113
-33% -$90.5K 0.01% 1765
2020
Q2 		$159K Buy
+39,580
New +$138K ﹤0.01% 1776
2019
Q4 		– Sell
-11,972
Closed -$55K – 2351
2019
Q3 		$55K Buy
+11,972
New +$94.3K ﹤0.01% 1871
2018
Q3 		– Sell
-56,900
Closed -$339K – 1745
2018
Q2 		$339K Buy
56,900
+39,900
+235% +$227K 0.01% 1212
2018
Q1 		$99K Hold
17,000
– – ﹤0.01% 1844
2017
Q4 		$100K Buy
+17,000
New +$93.1K ﹤0.01% 1795
2017
Q3 		– Sell
-17,833
Closed -$72K – 2281
2017
Q2 		$72K Sell
17,833
-107,167
-86% -$508K ﹤0.01% 2095
2017
Q1 		$711K Buy
125,000
+95,193
+319% +$603K 0.01% 1442
2016
Q4 		$217K Buy
+29,807
New +$187K ﹤0.01% 1815
2015
Q4 		– Sell
-16,379
Closed -$132K – 1828
2015
Q3 		$132K Sell
16,379
-7
-0% -$110 ﹤0.01% 1507
2015
Q2 		$397K Buy
+16,386
New +$517K 0.01% 1195

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

Paloma Partners's LAB Position: Q4 2024 in Review

Paloma Partners sold out of Standard BioTools (LAB) in Q4 2024, closing a stake of 11,183 shares — an estimated $21.6K sold.

Paloma Partners first reported a position in LAB in Q2 2015 and held it in 12 quarters. The position peaked at $711K in Q1 2017. 142 funds tracked by Wall St. Rank hold LAB as of Q4 2024.

  • Paloma Partners reported no remaining Standard BioTools position as of Q4 2024 after selling out during the quarter.
  • Paloma Partners sold 11,183 Standard BioTools shares in Q4 2024, an estimated $21.6K.
  • Paloma Partners first reported a position in Standard BioTools in Q2 2015 and held it in 12 quarters.
  • Paloma Partners's Standard BioTools position peaked at $711K in Q1 2017.
  • 142 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.